StockData
PolyPid Ltd. logo

PolyPid Ltd. (PYPD) stock

PYPDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 25, 2026Score 5/30
$6.54+0.39 (+6.34%)

Close on Nov 17, 2026Market cap $119.05MP/E 3.1Yield –

PolyPid r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $23.81M, up 4.4% from the year before. The highest annual figure on record is $30.55M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$23.81M+4.4%
FY2024Dec 31, 2024$22.81M+41.3%
FY2023Dec 31, 2023$16.15M-42.3%
FY2022Dec 31, 2022$27.99M-8.4%
FY2021Dec 31, 2021$30.55M+80.2%
FY2020Dec 31, 2020$16.95M+20.4%
FY2019Dec 31, 2019$14.08M+12.2%
FY2018Dec 31, 2018$12.55M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2025Jun 30, 2025$6.22M-16.5%
Q2 FY2024Jun 30, 2024$4.76M+9.7%
Q2 FY2023Jun 30, 2023$3.96M–
Q2 FY2022Jun 30, 2022$8.40M–
Q2 FY2021Jun 30, 2021$7.44M–
Q2 FY2020Jun 30, 2020$4.34M–

More PolyPid figures

See a number that looks wrong?